4-methylthiobenzaldehyde | 146857-81-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methylthiobenzaldehyde
• 英文别名: para-methylthiobenzaldehyde；4'-methylthiobenzaldehyde；4-methylthiobenzenaldehyde；p-methylthiobenzaldehyde
• CAS: 146857-81-0
• 化学式: C₈H₈S
• 分子量: 136.218
• InChiKey: PIMQQGJMDMAZGT-UHFFFAOYSA-N

物化性质

• 沸点：
  207.4±33.0 °C(Predicted)
• 密度：
  1.087±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  32.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-methylthiobenzaldehyde 在 sodium tetrahydroborate 、 NaOH 、 potassium carbonate 作用下， 生成 N-(4-(methylthio)benzyl)-N-(4-isopropylbenzyl)-1H-benzo[d]imidazol-5-amine
  参考文献：
  名称：

  NOVEL INHIBITORS

  摘要：

  新型杂环衍生物作为谷氨酰胺环化酶（QC，EC 2.3.2.5）的抑制剂。QC催化N-末端谷氨酸残基的分子内环化，生成丙氨酸内酰胺（5-氧代脯氨酰，pGlu*），同时释放氨气，以及N-末端谷氨酸残基的分子内环化，生成丙氨酸内酰胺，同时释放水。

  公开号：

  US20110262388A1

文献信息

• [EN] 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES AND THEIR USE AS 11-BETAHSD1 INHIBITORS<br/>[FR] DERIVES DE PIPERIDINE 1,4 DISUBSTITUEE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE 11-BETAHSD1
  申请人：ASTRAZENECA AB

  公开号：WO2004033427A1

  公开（公告）日：2004-04-22

  The use of a compound of formula (I) in the manufacture of a medicament for use in the inhibition of 11βHSD1 is described.

  使用式(I)的化合物制造用于抑制11βHSD1的药物。
• 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
  申请人：Pacific Corporation

  公开号：US06492416B1

  公开（公告）日：2002-12-10

  The present invention provides a novel class of 4,5-diaryl-3(2H)-furanone derivatives, which inhibit strongly and selectively COX-2 over COX-1. They are useful to treat inflammation, inflammation-associated disorders, and COX-2 mediated diseases.

  本发明提供了一类新型的4,5-二芳基-3(2H)-呋喃酮衍生物，其强烈且选择性地抑制COX-2而不抑制COX-1。它们可用于治疗炎症、与炎症相关的疾病和COX-2介导的疾病。
• THIAZOLIDINONE COMPOUNDS AND USE THEREOF
  申请人：National Health Research Institutes

  公开号：US20170253569A1

  公开（公告）日：2017-09-07

  A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

  一种含有化合物（I）的药物组合物，用于治疗与阿片受体相关的疾病。还公开了一种使用这种化合物治疗阿片受体相关疾病的方法。进一步公开了两组式（I）的噻唑烷酮化合物：（i）每种化合物的对映体过量大于90%；（ii）每种化合物被氘取代。
• Process for the preparation of carboxylic acids and derivatives of them
  申请人：BIOGAL GYOGYSZERGYAR

  公开号：EP0578850A1

  公开（公告）日：1994-01-19

  The subject matter of the invention is a process for the preparation of carboxylic acids and derivatives of them of the general formula wherein Rmeans hydrogen, or a C₁₋₄alkyl or a (C₁₋₅alkoxy)carbonyl group, R₁is as defined in claim 1, R₇stands for hydrogen or a C₁₋₇alkyl group and R₈means hydrogen or a carboxyl group, by reacting a 1,3-dioxane-4,6-dione derivative of the general formula wherein R₉stands for a C₁₋₄alkyl group or a phenyl group, optionally monosubstituted by halogen and R₁₀stands for hydrogen or a C₁₋₅alkyl group or R₉ and R₁₀together form a pentamethylene group, and an aldehyde or ketone of the general formula in the presence of formic acid and of [a] amine(s) and, if desired, of an alcohol of the general formula         R₇ - OH   VI, wherein R₇is a C₁₋₇alkyl group, at a temperature of 20 to 140°C,    and/or reducing an unsaturated 1,3-dioxane-4,6-dione derivative of the general formula    and/or a 1,3-dioxane-4,6-dione derivative of the general formula with formic acid in the presence of [a] amine(s) and, if desired, of an alcohol as above defined.

  本发明的主题是一种用于制备通式为的羧酸及其衍生物的过程    其中 R表示氢，或C₁₋₄烷基或(C₁₋₅烷氧基)甲酰基， R₁如权利要求1中定义， R₇代表氢或C₁₋₇烷基团和 R₈表示氢或羧酸基， 通过将通式为的1,3-二氧杂环己烷-4,6-二酮衍生物与醛或酮反应    其中 R₉代表C₁₋₄烷基或苯基，可选地由卤素单取代 R₁₀代表氢或C₁₋₅烷基或 R₉和R₁₀共同形成一个戊烷基， 在甲酸和[a]胺的存在下，如果需要，还可以在上述定义的醇的存在下，          R₇ - OH         VI,    其中 R₇是C₁₋₇烷基， 在20至140°C的温度下，     和/或 将通式的不饱和1,3-二氧杂环己烷-4,6-二酮衍生物还原     和/或 通式为的1,3-二氧杂环己烷-4,6-二酮衍生物 与甲酸在[a]胺的存在下，如果需要，还可以在上述定义的醇的存在下。
• Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
  申请人：Najib Jamila

  公开号：US20050171149A1

  公开（公告）日：2005-08-04

  The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives designed for therapeutic use. The inventive compositions are useful in particular for preventing or treating cardiovascular diseases, syndrome X, la restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms (benign or malignant tumors), neurodegenerative, dermatological diseases and disorders related to oxidative stress, for preventing or treating the effects of ageing in general and for example skin ageing, in particular in the field of cosmetics (occurrence of wrinkles and the like).

  这项发明涉及含有取代的1,3-二苯基丙-2-烯-1-酮衍生物的组合物，用于治疗用途。这些创新的组合物特别适用于预防或治疗心血管疾病、X综合征、再狭窄、糖尿病、肥胖、高血压、炎症性疾病、癌症或肿瘤（良性或恶性肿瘤）、神经退行性疾病、皮肤病和与氧化应激有关的紊乱，用于预防或治疗普遍衰老的影响，例如皮肤衰老，特别是在化妆品领域（皱纹等的出现）。